Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease-Reference-Cited by-同舟云学术

Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease

Published:2002-10 Issue:7 Volume:97 Page:1041-1048
ISSN:0074-0276
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Amaral VF¹,Teva A¹,Oliveira-Neto MP²,Silva AJ¹,Pereira MS¹,Cupolillo E¹,Porrozzi R¹,Coutinho SG¹,Pirmez C¹,Beverley SM³,Grimaldi Jr G¹

Affiliation:

1. Instituto Oswaldo Cruz

2. Fiocruz, Brasil

3. Washington University, USA

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v97n7/4555.pdf

Reference32 articles.

1. The Asian Rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis;Amaral VF;Exp Parasitol,1996

2. Leishmania (Leishmania) major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous reinfections;Amaral VF;Mem Inst Oswaldo Cruz,2001

3. Controlled field trials of a vaccine against New World cutaneous leishmaniasis;Antunes CM;Int J Epidemiol,1986

4. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up;Armijos RX;J Infect Dis,1998

5. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease;Campos-Neto A;Infect Immun,2001

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization;Frontiers in Public Health;2024-07-05

2. Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated Leishmania;Microorganisms;2023-04-16

3. The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates;Pathogens;2022-04-02

4. Host–Pathogen Interaction in Leishmaniasis: Immune Response and Vaccination Strategies;Immuno;2022-03-09

5. Vaccination in Leishmaniasis: A Review Article;IRAN BIOMED J;2022